Eyal Mishani
Chief Tech/Sci/R&D Officer at Hadassah University Hospital
Profile
Eyal Mishani was the founder of TK-Signal Ltd., a company founded in 2001, where he held the title of Chief Technology Officer from 2001 to 2010.
Currently, Dr. Mishani holds multiple positions.
He is the Director at Hadasit Medical Research Services & Development Ltd.
since 2014.
He is also a Lecturer at The Hebrew University of Jerusalem and the Head of Research & Development at Hadassah University Hospital.
Dr. Mishani obtained a doctorate degree from Tel-Aviv University.
Eyal Mishani active positions
Companies | Position | Start |
---|---|---|
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel. | Chief Tech/Sci/R&D Officer | - |
The Hebrew University of Jerusalem | Corporate Officer/Principal | - |
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Director/Board Member | 2014-06-23 |
Former positions of Eyal Mishani
Companies | Position | End |
---|---|---|
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Founder | - |
Training of Eyal Mishani
Tel-Aviv University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Health Technology |
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel. | Health Services |
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Commercial Services |
- Stock Market
- Insiders
- Eyal Mishani